Related Experiment Video
Updated: Jan 17, 2026

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
Does Home COVID-19 Testing Bias COVID-19 Vaccine Effectiveness Estimates?
Mary Patricia Nowalk1, G K Balasubramani2, Helen D'Agostino2
1Department of Family Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Home COVID-19 testing is linked to higher vaccination rates and may influence vaccine effectiveness estimates. Patients using home tests differ from those who don't, impacting public health data accuracy.
Area of Science:
- Epidemiology
- Public Health
- Infectious Disease
Background:
- COVID-19 home testing became prevalent in early 2021.
- Home testing may impact care-seeking behaviors for acute respiratory illness.
- It can also influence the accuracy of COVID-19 vaccine effectiveness estimates.
Purpose of the Study:
- To assess the association between home COVID-19 testing and care-seeking behavior.
- To evaluate the impact of home testing on COVID-19 vaccine effectiveness estimates.
- To understand demographic and clinical factors associated with home testing.
Main Methods:
- A test-negative case-control study was conducted from January to May 2022.
- Outpatients with acute respiratory illness were surveyed about home COVID-19 testing and tested for SARS-CoV-2.
- Multivariable logistic regression analyzed associations between home testing, care seeking, and vaccine effectiveness.
Main Results:
- Home testing was associated with current vaccination, cough, higher education, and not having a prior positive test.
- COVID-19 illness correlated with cough, contact with a case, and home testing.
- Adjusted vaccine effectiveness was 35% (95% CI=22%, 45%), slightly increasing to 37% (95% CI=13%, 46%) when home testing was included. Effectiveness was lower in those who home tested (31%) versus those who did not (43%).
Conclusions:
- Patients utilizing home COVID-19 tests before seeking care differ from non-users.
- These differences can potentially bias estimates of COVID-19 vaccine effectiveness.
- Further research is needed to understand and account for these variations in specific populations.
More Related Videos
06:08Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bias in Epidemiological Studies
Vaccinations
Bioequivalence Data: Statistical Interpretation
Accuracy and Errors in Hypothesis Testing
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
Confounding in Epidemiological Studies